BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11188932)

  • 1. Cancer immunotherapy using dendritic cell-derived exosomes.
    Amigorena S
    Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exosomes derived from dendritic cells].
    Amigorena S
    J Soc Biol; 2001; 195(1):25-7. PubMed ID: 11530496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exosomes and anti-tumour immunotherapy].
    Chaput N; Andre F; Schartz NE; Flament C; Angevin E; Escudier B; Zitvogel L
    Bull Cancer; 2003; 90(8-9):695-8. PubMed ID: 14609758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses.
    Segura E; Amigorena S; Théry C
    Blood Cells Mol Dis; 2005; 35(2):89-93. PubMed ID: 15990342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.
    Théry C; Duban L; Segura E; Véron P; Lantz O; Amigorena S
    Nat Immunol; 2002 Dec; 3(12):1156-62. PubMed ID: 12426563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells.
    Mallegol J; Van Niel G; Lebreton C; Lepelletier Y; Candalh C; Dugave C; Heath JK; Raposo G; Cerf-Bensussan N; Heyman M
    Gastroenterology; 2007 May; 132(5):1866-76. PubMed ID: 17484880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells.
    Véron P; Segura E; Sugano G; Amigorena S; Théry C
    Blood Cells Mol Dis; 2005; 35(2):81-8. PubMed ID: 15982908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct exosome stimulation of peripheral human T cells detected by ELISPOT.
    Admyre C; Johansson SM; Paulie S; Gabrielsson S
    Eur J Immunol; 2006 Jul; 36(7):1772-81. PubMed ID: 16761310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes: endosomal-derived vesicles shipping extracellular messages.
    Février B; Raposo G
    Curr Opin Cell Biol; 2004 Aug; 16(4):415-21. PubMed ID: 15261674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of exosomes in immunotherapy of cancer.
    Chaput N; Taïeb J; Schartz N; Flament C; Novault S; André F; Zitvogel L
    Blood Cells Mol Dis; 2005; 35(2):111-5. PubMed ID: 16027014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanovesicular vaccines: exosomes.
    Li X; Zhang Z; Beiter T; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):329-35. PubMed ID: 16088317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
    Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X
    Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.
    Schartz NE; Chaput N; André F; Zitvogel L
    Curr Opin Mol Ther; 2002 Aug; 4(4):372-81. PubMed ID: 12222875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
    Dai S; Wan T; Wang B; Zhou X; Xiu F; Chen T; Wu Y; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7554-63. PubMed ID: 16243831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar immune responses and antitumor effects of murine dendritic cells loaded with either exogenous or endogenous-synthesized protein.
    Lacave R; Masurier C; Guigon M; Lemoine FM; Klatzmann D; Colombo BM
    Int J Oncol; 2003 Dec; 23(6):1747-53. PubMed ID: 14612950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
    Cho JA; Lee YS; Kim SH; Ko JK; Kim CW
    Cancer Lett; 2009 Mar; 275(2):256-65. PubMed ID: 19036499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-released exosomes and their implications in cancer immunity.
    Iero M; Valenti R; Huber V; Filipazzi P; Parmiani G; Fais S; Rivoltini L
    Cell Death Differ; 2008 Jan; 15(1):80-8. PubMed ID: 17932500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.